HAFFKINE BIO-PHARMACEUTICAL CORPORATION LTD., GOVERNMENT OF MAHARASHTRA UNDERTAKING THROUGH MANAGER versus M/S. NIRLAC CHEMICALS THROUGH ITS MANAGER & ORS.
Open in Lexace · Ask the AI about this caseJudgment (excerpt)
[2017] 8 S.C.R. 450 A HAFFKINE BIO-PHARMACEUTICAL CORPORATION LTD., A GOVERNMENT OF MAHARASHTRA UNDERTAKING THROUGH MANAGER v. MIS. NIRLAC CHEMICALS THROUGH ITS MANAGER & B ORS. c (Civil Appeal No. 9836 of 2017) JULY27,2017 [MADAN B. LOKUR AND DEEPAK GUPTA, JJ.J Tender: Validity of tender - Challenged by unsuccessful bidder - On the ground that technical-cum-commercial bid was not opened in the presence of its representatives - High Court set aside the award of tender - On appeal, held: Opening of the the tender of the D successful bidder in absence of the challenging bidder, is in violation of Central Vigilance Commission Guidelines - However, since the unsuccessful bidder did not fulfill all the tender conditions, its tender was also not technically qualified - Jn the interest of justice, the tendering company is restrained from purchasing any further, from E the successful bidder and is further directed to place order with the unsuccessful bidder in respect of the pending orders - The tendering company is permitted to float fresh tender as e-tender with clear and unambiguous terms and conditions - Contract. F Disposing of the appeals, the Court HELD: 1. A bare reading of the Central Vigilance Commission (CVC) guidelines clearly shows that the tender must be opened in the presence of the bidders or representatives of the bidders who are present at the time when the bid is opened. The High Court, after going through the entire record, came to G the conclusion that the bid of the successful bidder had not been opened in the presence of the representatives of unsuccessful bidder. In fact, this was admitted by the appellant before the High Court. Even before this Court, no record could be produced to show that the bid of the successful bidder was opened in the presence of the representatives of the unsuccessful bidder. In H 450 HAFFKINE BIO-PHARMACEUTICAL CORP. LTQ. v. NIRLAC 451 CHEMICALS THR ITS MANAGER ยท this view of the matter, the entire tender opening process is ยทA vitiated since the CVC guidelines have not been followed. [Paras 9, 10)[457-B-C, Er 2. Opening of the tender without showing the documents is also meaningless. When. a technical bid is .opened, it is the right of the rival bidders to see whether the documents attached B by a bidder meet the technical requirements or liot. This can only .be done if the documents attached to the bid are shown to the other side. [Para 10)(457-FJ' 3. The case of the unsuccessful bidder is that till 22.06.2016 they were not aware of the rejection of their bid. This assertion c is patently false. The comparative analysis chart prepared by the appellant was admittedly shown to the representatives of the unsuccessful bidder on the evening of 12.02.2016 itself. This is also apparent from the facts that on 12.02.2016, the unsuccessful bidder sent a letter to the tendering Company protesting against the rejection of their bid. In this letter they have mentioned that D at about 5.45 p,m., a comparative analysis sheet was shown to the representatives ยทof the unsuccessful bidder. They have listed out several conditions of the tender bid. With regard to 7 points, they have objected that they bad given all the requisite information and their bid had been wrongly rejected. They have given detailed E reasons for the same; Therefore,. it cannot be said that the unsuccessful bidder was not aware of the fact that their bid had not been found to be technically qualified. [Para 11)1457-G-H; 458-F-G) 4. It is not correct to say that the unsuccessful bidder should F be compensated for the loss suffered by it. A party can only claim restitution when its bid is technically qualified and wrongly rejected. The High Court erred in holding that the unsuccessful bidder satisfied all the tender conditions. Condition 'j' of the Tender Notice clearly postulates that the bidder should be able to generate business for the tendering Company for sale of G minimum 70 million doses. It may be correct that there is no mention of any buy back arrangement but it is apparent that the ยท tendering Company wanted that the person supplying the bulk drug should also generate business for sale of 70 million doses H 452 SUPREME COURT REPORTS [2017] 8 S.C.R. A of the finished product. This is the only interpretation which can be given to condition 'j'. Since the unsuccessful bidder did not fulfil this condition, its tender was not f
Excerpt shown. Read the full judgment & AI analysis in Lexace.
Lex